MedPath

SYNMOSA BIOPHARMA (HONG KONG) COMPANY LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

93

PPB:93

Drug Approvals

ATOTIN TABLETS 10MG

Approval Date
Nov 27, 2024
PPB

ATOTIN TABLETS 20MG

Approval Date
Nov 27, 2024
PPB

SYNBOT TABLETS 20MG

Approval Date
Nov 1, 2024
PPB

SYNBOT TABLETS 5MG

Approval Date
Nov 1, 2024
PPB

KIMODIN TABLETS 20MG

Approval Date
Jun 7, 2024
PPB

SYNTRODINE TABLETS 200MG

Approval Date
Mar 28, 2024
PPB

SYNPID TABLETS 160MG

Approval Date
Feb 26, 2024
PPB

MEGEJOHN TABLETS 40MG

Approval Date
Feb 26, 2024
PPB

AMLOS TABLETS 5MG

Approval Date
Nov 30, 2023
PPB

ACTEIN EFFERVESCENT GRANULES 600MG

Approval Date
Oct 30, 2023
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.